Ca. Ramsay et al., Calcipotriol cream combined with twice weekly broad-band UVB phototherapy:A safe, effective and UVB-sparing antipsoriatric combination treatment, DERMATOLOGY, 200(1), 2000, pp. 17-24
Background: Calcipotriol has been combined with a number of systemic antips
oriatric treatments, improving efficacy or reducing the systemic treatment
required. Although studies on calcipotriol and UVB have also been performed
, there are no data on the UVB-saving effect of calcipotriol combined with
broad-band UVB to reduce overall UVB exposure, while maintaining efficacy.
Objectives: To assess the efficacy and safety of calcipotriol cream (50 mu
g/g) combined with twice weekly broad-band UVB and to determine if this tre
atment would require fewer UVB treatments and lower cumulative UVB irradian
ce when compared to a standard 3 times weekly broad-band UVB regime in pati
ents with extensive psoriasis. Methods: This multicentre, prospective, rand
omised, parallel-group, vehicle-controlled, single-blind (investigator) stu
dy consisted of a 1-week wash-out phase, 12-week treatment phase and 12-wee
k follow-up phase. Broad-band UVB equipment was standardised and calibrated
prior to the study. The UVB starting dose was based on the patient's minim
al erythema dose. Assessments included PASI, extent, severity and investiga
tor and patient's overall assessments of the psoriasis. Results: Fewer expo
sures (12 vs. 19) and less cumulative UVB irradiance (1,570 vs. 5,430 mJ/cm
(2)) were required by the calcipotriol + twice weekly UVB group to achieve
80% reduction in PASI (p < 0.001). Similarly, fewer exposures (22 vs. 25) a
nd less cumulative UVB irradiance (4,147 vs. 9,670 mJ/cm(2)) were required
by this group to achieve total clearance (p < 0.001). There was no differen
ce in the PASI, patient's and investigator's overall assessments and number
of adverse events recorded by either group for both the treatment and foll
ow-up phases. Conclusion: Calcipotriol cream + twice weekly broad-band UVB
phototherapy is an effective and safe antipsoriatric treatment, resulting i
n fewer UVB exposures, lower cumulative irradiance and a saving of time. Co
pyright (R) 2000 S. Karger AG. Basel.